Athenex files proceedings under Chapter 11 of US Bankruptcy Code
Pharma Leaders
MAY 15, 2023
This will allow the company to satisfy certain obligations to its vendors for authorised goods received and services rendered after the filing. Athenex CEO Dr Johnson Lau said: “Our team was successful in bringing tirbanibulin, through regulatory approvals, to the US market and a number of EU countries, as well as Taiwan.
Let's personalize your content